Towards a more precise and individualized assessment of breast cancer risk.

Aging (Albany NY) 2019 02;11(4):1305-1316

University of Vermont Cancer Center, The Robert Larner MD College of Medicine, University of Vermont, Burlington, VT 05405, USA.

Many clinically based models are available for breast cancer risk assessment; however, these models are not particularly useful at the individual level, despite being designed with that intent. There is, therefore, a significant need for improved, precise individualized risk assessment. In this Research Perspective, we highlight commonly used clinical risk assessment models and recent scientific advances to individualize risk assessment using precision biomarkers. Genome-wide association studies have identified >100 single nucleotide polymorphisms (SNPs) associated with breast cancer risk, and polygenic risk scores (PRS) have been developed by several groups using this information. The ability of a PRS to improve risk assessment is promising; however, validation in both genetically and ethnically diverse populations is needed. Additionally, novel classes of biomarkers, such as microRNAs, may capture clinically relevant information based on epigenetic regulation of gene expression. Our group has recently identified a circulating-microRNA signature predictive of long-term breast cancer in a prospective cohort of high-risk women. While progress has been made, the importance of accurate risk assessment cannot be understated. Precision risk assessment will identify those women at greatest risk of developing breast cancer, thus avoiding overtreatment of women at average risk and identifying the most appropriate candidates for chemoprevention or surgical prevention.

Download full-text PDF

Source
http://dx.doi.org/10.18632/aging.101803DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402518PMC
February 2019
1 Read

Publication Analysis

Top Keywords

risk assessment
28
breast cancer
20
risk
12
cancer risk
12
assessment models
8
precise individualized
8
assessment
8
breast
5
cancer
5
prs improve
4
improve risk
4
groups ability
4
will identify
4
assessment will
4
ability prs
4
validation genetically
4
understated precision
4
ethnically diverse
4
genetically ethnically
4
precision risk
4

Similar Publications